Among the molecule-targeting drugs for unresectable advanced recurrent colorectal cancer that are listed in the current NCCN's Guidelines for Treatment of Colorectal Cancer [13], many of the angiogenesis-related drugs target VEGF-associated molecules. Here, VEGFA is linked to colorectal cancer.